Alto Neuroscience, Inc.ANRONYSE
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-51.79M
↓ 56% vs avg
Percentile
P0
Near historical low
Streak
4 yr
Consecutive declineContracting
Average
$-33.26M
Historical baseline
PeriodValueYoY Change
2025$-51.79M-4.6%
2024$-49.50M-45.9%
2023$-33.92M-60.6%
2022$-21.13M-112.5%
2021$-9.94M-